Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies

JE Tota, M Chevarie-Davis, LA Richardson… - Preventive …, 2011 - Elsevier
Human papillomavirus (HPV) infection is a necessary, although not sufficient cause of
cervical cancer. Globally, HPV infection accounts for an estimated 530,000 cervical cancer …

Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study

AR Giuliano, JH Lee, W Fulp, LL Villa, E Lazcano… - The Lancet, 2011 - thelancet.com
Summary Background Human papillomaviruses (HPVs) cause genital warts and cancers in
men. The natural history of HPV infection in men is largely unknown, and that information is …

Considerations for human papillomavirus (HPV) vaccination of mid-adult women in the United States

LA Grant, EF Dunne, H Chesson, LE Markowitz - Vaccine, 2011 - Elsevier
In the United States, human papillomavirus (HPV) vaccination is recommended for 11 or 12
year old girls, with catch-up vaccination through age 26 years. Data are available for women …

[HTML][HTML] Outcome of expectant management of cervical intraepithelial neoplasia grade 2 in women followed for 12 months

MG Discacciati, CAS de Souza, MG d'Otavianno… - European Journal of …, 2011 - Elsevier
OBJECTIVE: To evaluate the outcome of CIN 2 diagnosed by colposcopy-directed biopsy in
women followed without treatment for 12 months and to verify whether the regression and …

Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancer

PE Castle, AC Rodríguez, RD Burk… - Journal of Infectious …, 2011 - academic.oup.com
Background. Detailed descriptions of long-term persistence of human papillomavirus (HPV)
in the absence of cervical precancer are lacking. Methods. In a large, population-based …

HPV E6/E7 mRNA testing is more specific than cytology in post-colposcopy follow-up of women with negative cervical biopsy

SW Sørbye, M Arbyn, S Fismen, TJ Gutteberg… - PloS one, 2011 - journals.plos.org
Background In Norway, women with negative or low-grade cervical biopsies (normal/CIN1)
are followed up after six months in order to decide on further follow-up or recall for screening …

Persistence of immune response to HPV-16/18 AS04-adjuvanted cervical cancer vaccine in women aged 15-55 years

TF Schwarz, M Spaczynski, A Schneider… - Human …, 2011 - Taylor & Francis
The HPV-16/18 AS04-adjuvanted vaccine (Cervarix®, GlaxoSmithKline Biologicals) has
been shown to induce a robust immune response in women aged 15-55 years (103514 …

Prevalence of human papillomavirus infection and associated risk factors in young women in Brazil, Canada, and the United States: a multicenter cross-sectional …

CM Roteli-Martins, NS de Carvalho… - International Journal …, 2011 - journals.lww.com
To determine the prevalence of cervical human papillomavirus (HPV) infection and risk
factors in young women from Brazil, Canada, and the USA. Cross-sectional study in 3204 …

Human papillomavirus infection in nasal polyps in a Chinese population

F Pei, XP Chen, Y Zhang, Y Wang… - Journal of General …, 2011 - microbiologyresearch.org
In order to determine the prevalence and genotype distribution of human papillomavirus
(HPV) infection in patients with nasal polyps, a total of 204 patients with nasal polyps and 36 …

Human papillomavirus vaccine: widening the scope for cancer prevention

JH No, MK Kim, YT Jeon, YB Kim… - Molecular …, 2011 - Wiley Online Library
Human papillomavirus (HPV) is the necessary cause of cervical cancer. The HPV
oncoproteins E6 and E7 have crucial roles in various steps of carcinogenesis, inducing …